HIGHLIGHTS
- who: Abatacept . Individual funding and collaborators from the Department of Rheumatology, Wirral University Teaching Hospital, Wirral, UK have published the Article: Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales, in the Journal: (JOURNAL)
- what: This study had a relatively short follow-up (mean 0 12 months).
SUMMARY
A multiple technology Clin Rheumatol 31:1005-1012 appraisal (MTA195) issued by NICE compared the clinical benefits and cost-effectiveness of treatment with a second antiTNF, the B-cell depleting anti . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.